Addition of stereotactic body radiotherapy (SBRT) to chemotherapy in locally advanced biliary tract cancers

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-003656-31

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Feasibility: The main objective of the feasibility part of the trial is to determine if it is feasible to deliver SBRT in a multicentre trial setting in a rare disease. In particular, will clinicians recruit to the trial and will sufficient patients accept randomisation. Phase II: The main objective of this trial to find out if giving SBRT after chemotherapy is better than giving chemotherapy on its own to treat patients with locally advanced biliary tract cancer (BTC).


Critère d'inclusion

  • Locally advanced biliary tract cancer

Liens